Review Article
Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
Table 1
Summary of mesenchymal stroma cell nomenclature.
| Nomenclature | Year | Authors’ references |
| CFU-F and osteogenic stem cells |
1974 |
Friedenstein et al. [10] | Stromal stem cells | 1988 |
Owen and Friedenstein [16] | Mesenchymal stem cells | 1991 | Caplan [17] | Mesenchymal progenitor cells | 1999 | Dennis et al. [18] | Skeletal stem cells | 2000 |
Bianco and Robey [19] | MAPCs and mesodermal progenitor cells | 2002 | Jiang et al. [20] | Multipotent mesenchymal stromal cells | 2006 | Dominici et al. (ISCT) [21] | Medicinal signalling cells | 2010 | Caplan [22] |
|
|
CFU-F: colony-forming unit fibroblasts; MAPCs: multipotent adult progenitor cells; ISCT: International Society for Cell Therapy.
|